Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses

Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neu...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shibo, Hillyer, Christopher, Du, Lanying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129017/
https://www.ncbi.nlm.nih.gov/pubmed/32249063
http://dx.doi.org/10.1016/j.it.2020.03.007
Descripción
Sumario:Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.

Ejemplares similares